Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Orion Corporation, Orion Pharma clinical trials
The registry lists 101 studies whose lead sponsor is Orion Corporation, Orion Pharma. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 22, 2026.
Keep track of what changes. Save the Orion Corporation, Orion Pharma studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Orion Corporation, Orion Pharma.
- Orion Corporation, Orion Pharma101 studiesSame company
Something wrong?
Focus areas
Conditions Orion Corporation, Orion Pharma leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 101. Browse all 101 →
- A 2-part Phase 1/2 Open-label Trial on ODM-212RecruitingNCT07563738Phase 1/2
- Trial to Study the Safety, Pharmacokinetics and Preliminary Antitumour Activity of ODM-216 in Patients With CancerRecruitingNCT07805252Phase 1/2
- A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid TumoursRecruitingNCT06725758Phase 1/2
- Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate CancerActive, not recruitingNCT03436485Phase 1/2
- Efficacy and Tolerability of Tasipimidine in Sleepless PatientsCompletedNCT06956495Phase 2
- Effect of Electronic Monitoring and Feedback on Adherence to Easyhaler Controller Medication in Patients With AsthmaCompletedNCT04869384Phase 4
- Safety and Pharmacokinetics of ODM-209CompletedNCT03878823Phase 1/2
- Digital Therapeutics (DTx) for Pain: Pilot Study of a Virtual Reality Software for Chronic PainCompletedNCT04225884Not applicable
- Efficacy and Safety of Remo-Wax® Oil (RWO) in Subjects With Isolated Itching of the External Ear CanalCompletedNCT05811039Not applicable
- Use of Buventol Easyhaler and Bufomix Easyhaler in Methacoline Challenge TestingCompletedNCT05084222Phase 4
- Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label ExtensionTerminatedNCT03948178Phase 3
- Comparison of Tiotropium Absorption From Tiotropium Easyhaler and Spiriva HandiHalerCompletedNCT05246046Phase 1
- Study to Compare Relative Bioavailability of 3 Indacaterol/Glycopyrronium Test Products and Reference ProductCompletedNCT05288075Phase 1
- Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALSCompletedNCT03505021Phase 3
- Pharmacokinetic Study Comparing Tiotropium Easyhaler® and Spiriva® HandiHaler®CompletedNCT04850144Phase 1
- Absorption of Indacaterol and Glycopyrronium From Ultibro BreezhalerCompletedNCT04856098Phase 1
- Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in NorwayTerminatedNCT04663386
- Dose-finding Pharmacokinetic Study in Healthy MalesCompletedNCT03055936Phase 1
- Safety and Efficacy of ORM-12741 in Patients With Alzheimer's DiseaseCompletedNCT01324518Phase 2
- Blood-Brain Barrier Penetration of Therapeutic Agents in HumanCompletedNCT04571996Phase 1
- Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate CancerCompletedNCT01784757Phase 1
- Salmeterol/Fluticasone Easyhaler in the Treatment of Asthma and COPDCompletedNCT03755544
- Inspiratory Flow Parameters With Placebo Easyhaler and Placebo HandiHalerCompletedNCT04147572Not applicable
- Safety and Tolerability of ODM-203 in Subjects With Advanced Solid TumoursCompletedNCT02264418Phase 1
- Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT02344017Phase 1/2
- ODM-207 in Patients With Advance Solid TumoursCompletedNCT03035591Phase 1/2
- Effect of Charcoal on Gastrointestinal Absorption of TiotropiumCompletedNCT03945344Phase 1
- Non-interventional Comparison of Sedatives on Weaning From Mechanical Ventilation in Intensive Care PatientsTerminatedNCT01707680
- Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at HomeTerminatedNCT01783132Not applicable
- Efficacy and Safety of Remo-Wax for Removal of Impacted EarwaxCompletedNCT03802903Not applicable
- Impact of Changing the Dosing Regimen on the PK Profile of ODM-203CompletedNCT03240445Phase 1
- Safety, Tolerability and Efficacy of DEXDOR in Pediatric Patients in ICUCompletedNCT03813277Phase 4
- Pharmacokinetic Study Comparing Tiotropium Easyhaler and Spiriva HandihalerCompletedNCT03400241Phase 1
- Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (SAIMI)CompletedNCT03238482Phase 1
- Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC)CompletedNCT02764125Phase 2
- Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's DiseaseCompletedNCT02471196Phase 2
- Effects of ODM-109 on Respiratory Function in Patients With Amyotrophic Lateral SclerosisCompletedNCT02487407Phase 2
- Pharmacokinetic of Levodopa Study in Healthy MalesCompletedNCT03140956Phase 1
- Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of ODM-108: in Healthy Male VolunteersTerminatedNCT02432664Phase 1
- Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate CancerCompletedNCT01317641Phase 1/2
- Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients.CompletedNCT00219388Phase 4
- Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort TurbuhalerCompletedNCT03073057Phase 1
- Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler and Seretide DiskusCompletedNCT03060044Phase 1
- Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001CompletedNCT01429064Phase 2
- Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy VolunteersCompletedNCT02393950Phase 1
- Pharmacokinetic Study in Healthy VolunteersCompletedNCT02554734Phase 1
- Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide DiskusCompletedNCT02162485Phase 1
- To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference ProductCompletedNCT02308098Phase 3
- Mass Balance, Pharmacokinetics, Biotransformation and Bioavailability Study of ODM-201 in Healthy Male SubjectsCompletedNCT02418650Phase 1
- Pharmacokinetic Study of Multiple Doses of ORM-12741 (Nebula PK 2)CompletedNCT02303860Phase 1